Next Generation Strategies for Cancer Immunotherapy


Over the past decade immunotherapy has emerged as a promising therapeutic strategy. However, treatment efficacy and resistance remain huge obstacles. In this webinar, two leading researchers discuss their innovative approaches to developing novel opportunities for immunotherapy treatments.

Dr. Seth Coffelt presents new data on the function of gamma delta T cells in breast and colorectal cancer mouse models, while Dr. Khalid Shah dives into the major discoveries his group has made in gene edited and engineered cell-based immunotherapies for cancer.